Content |
History
2023: Ministry of Ecology of the Moscow Region: Globalkhimpharm arranged a landfill instead of pharmaceutical production
On November 27, 2023, the Ministry of Ecology and Nature Management of the Moscow Region announced the creation by Globalkhimpharm of an illegal landfill in Dolgoprudny. Local eco-activists sent a complaint about the dumping of garbage at the site to the department.
According to the press service of the Ministry of Ecology of the Moscow Region, the department sent a warning to the pharmaceutical company Globalkhimpharm (a subsidiary of the Pharmstandard holding) about the inadmissibility of violations after a landfill of construction waste was found on a leased site in the Dolgoprudny urban district. It is specified that the area of the illegal landfill is about 1 hectare.
During the inspection of the territory, police officers detained and sent an excavator to a special parking lot, with the help of which construction waste was placed. Therefore, the tenant was issued a warning demanding to stop illegal waste management activities, the press service of the department noted, adding that the situation remains under the control of the ministry. |
Earlier, Globalkhimpharm entered into a land lease agreement with the Dolgoprudny administration in early 2023 with the aim of organizing an import-substituting production of pharmaceutical substances on this territory. The site was provided on preferential terms - under the regional program for supporting import-substituting projects "Earth for 1 ruble."
Globalchimpharm LLC has been operating in the Moscow region since 2015, it is an enterprise of the pharmaceutical holding Pharmstandard JSC and specializes in the development of technologies for the synthesis, production and purification of active pharmaceutical substances.[1]
2022: Creation of the production of pharmaceutical substances for 750 million rubles
On May 18, 2022, it became known about the creation of a production of pharmaceutical substances in Dolgoprudny near Moscow. This project with investments of 750 million rubles is being implemented by Globalkhimpharm, the press service of the Ministry of Investment, Industry and Science of the Moscow Region reports.
Within the framework of the new enterprise, about 120 jobs will be created, as a result of which the number of Globalkhimpharm personnel will triple, and "residents of the Dolgoprudny urban district will be able to find work near their home," said Deputy Prime Minister - Minister of Investment, Industry and Science of the Moscow Region Ekaterina Zinovieva.
The press service of the ministry added that at the new enterprise, residents of the urban district and the nearest districts will be able to find work in the following specialties: chemist, chemical technologist, engineer, apparatchik, analyst, laboratory assistant, locksmith.
It is expected that the Globalchimpharm project will significantly reduce the dependence of the Russian market on the import of pharmaceutical substances for the most important drugs. The expanded portfolio of Globalchimpharm LLC will include active pharmaceutical substances of such strategically important pharmacological groups as antitumor drugs and immunomodulators; hormonal drugs for systemic use; drugs for the treatment of diseases of the musculoskeletal system; drugs for the treatment of diseases of the respiratory system.
Globalchimpharm LLC is an enterprise of Pharmstandard JSC pharmaceutical holding and specializes in the development of technologies for the synthesis, production and purification of active pharmaceutical substances (APIs), validation of analytical methods to ensure quality control of manufactured APIs.[2]